Results from Active Biotech's Phase II/III Anyara trial for the treatment of renal cell cancer

Home › Results from Active Biotech's Phase II/III Anyara trial for the treatment of renal cell cancer

Active Biotech announced today the initial results from the ANYARA Phase II/III clinical study.

06.10	Weekly Recap: Ontex Enters Agreement to Sell Brazilian Business, Winner Acquires Stake in GRI ...
06.10	Tropical Storm Milton Graphics
06.10	Tropical Storm Milton Public Advisory Number 4A
06.10	Summary for Tropical Storm Milton (AT4/AL142024)
06.10	Atlantic Tropical Weather Outlook
06.10	Eastern North Pacific Tropical Weather Outlook
06.10	Ex-cabinet secretary says 200,000 job is underpaid
06.10	Hurricane Leslie Graphics
More »

je.st